Hepatocellular Cancer Unknown Status Phase 4 Trials for Sorafenib (DB00398)

Also known as: Cancer, Hepatocellular

IndicationStatusPhase
DBCOND0037277 (Hepatocellular Cancer)Unknown Status4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01849588Sorafenib for Hepatocellular Cancer With Chronic Hepatitis CTreatment